GH RESEARCH PLC Share Price Today: Live Updates & Key Insights

GH RESEARCH PLC share price today is $13.97, up -5.67%. The stock opened at $14.83 against the previous close of $14.81, with an intraday high of $14.92 and low of $13.9.

GH RESEARCH PLC Share Price Chart

GH RESEARCH PLC

us-stock
To Invest in {{usstockname}}
us-stock

GH RESEARCH PLC Share Price Performance

$13.97 -0.0567(-5.67%) GHRS at 23 Mar 2026 01:18 PM Biotechnology
Lowest Today 13.9
Highest Today 14.92
Today’s Open 14.83
Prev. Close 14.81
52 Week High 19.51
52 Week Low 7.98
Day’s Range: Low 13.9 High 14.92
52-Week Range: Low 7.98 High 19.51
1 day return -
1 Week return -7.31
1 month return -9.24
3 month return +7.23
6 month return +3.22
1 year return +9.16
3 year return +139.93
5 year return -28.8
10 year return -

GH RESEARCH PLC Institutional Holdings

Bvf Inc 14.23

Lynx1 Capital Management, LP 13.87

RA Capital Management, LLC 12.38

RTW INVESTMENTS, LLC 9.57

FMR Inc 8.28

Fidelity Growth Compy Commingled Pl S 4.16

Cormorant Asset Management, LLC 3.09

venBio Select Advisor LLC 2.90

Fidelity Growth Company Fund 2.51

Deep Track Capital, LP 2.02

RTW Biotech Opportunities Ord 1.30

Jefferies Financial Group Inc 1.14

Verition Fund Managegment, LLC 1.09

5AM Venture Management, LLC 0.92

Fidelity Growth Company K6 0.85

UBS Group AG 0.82

Fidelity Series Growth Company 0.61

iShares Biotechnology ETF 0.54

Squadron Capital Management LLC 0.51

Millennium Management LLC 0.48

CenterBook Partners LP 0.46

Marshall Wace Asset Management Ltd 0.39

HighVista Strategies LLC 0.39

Alyeska Investment Group, L.P. 0.33

BOOTHBAY FUND MANAGEMENT, LLC 0.18

Fidelity Select Biotechnology 0.15

AdvisorShares Psychedelics ETF 0.13

Point72 Asset Management, L.P. 0.12

iShares MSCI Ireland ETF 0.09

iShares Nasdaq US Biotech ETF USD Acc 0.08

Fidelity Nasdaq Composite Index 0.06

A4Investments SICAV SIF ACCI IlanaA2EURH 0.05

Arrow Long/Short Alt Fd F 0.05

Arrow Opportunities Alternative Series F 0.05

Virtus LifeSci Biotech Clinical Trls ETF 0.03

Exemplar Performance Series F 0.02

State Street® SPDR® S&P® Intl Sm Cp ETF 0.02

TEQ- Disruptive Tech In I-III 0.01

Northern Small Cap Core I 0.01

Invesco Nasdaq Biotechnology ETF 0.01

GH RESEARCH PLC Market Status

Strong Buy: 5

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

GH RESEARCH PLC Fundamentals

Market Cap 866.55 M

PB Ratio 3.2906

PE Ratio 0.0

Enterprise Value 586.35 M

Total Assets 288.23 M

Volume 240030

GH RESEARCH PLC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:-315000 -0.3M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-35587000 -35.6M, FY22:-7135000 -7.1M, FY21:-9211000 -9.2M, FY20:-446000 -0.4M, FY19:-310000 -0.3M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-89000 -0.1M, Q2/2025:-82000 -0.1M, Q1/2025:-76000 -0.1M, Q3/2024:null 0.0M, Q2/2024:-78000 -0.1M

Quarterly Net worth Q3/2025:-14020000 -14.0M, Q2/2025:-9289000 -9.3M, Q1/2025:-10812000 -10.8M, Q3/2024:-12114000 -12.1M, Q2/2024:-10379000 -10.4M

About GH RESEARCH PLC & investment objective

Company Information GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

Organisation Biotechnology

Employees 73

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

GH RESEARCH PLC FAQs

What is the share price of GH RESEARCH PLC today?

The current share price of GH RESEARCH PLC is $13.97.

Can I buy GH RESEARCH PLC shares in India?

Yes, Indian investors can buy GH RESEARCH PLC shares by opening an international trading and demat account with Motilal Oswal.

How to buy GH RESEARCH PLC shares in India?

You can easily invest in GH RESEARCH PLC shares from India by:

Can I buy fractional shares of GH RESEARCH PLC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of GH RESEARCH PLC?

GH RESEARCH PLC has a market cap of $866.55 M.

In which sector does GH RESEARCH PLC belong?

GH RESEARCH PLC operates in the Biotechnology sector.

What documents are required to invest in GH RESEARCH PLC stocks?

To invest, you typically need:

What is the PE and PB ratio of GH RESEARCH PLC?

The PE ratio of GH RESEARCH PLC is N/A and the PB ratio is 3.29.